首页> 外国专利> polynucleotides, isolated adenovirus, virus-like particle, vector, composition, cell and in vitro method for the production of an adenovirus or adenovirus-like particle

polynucleotides, isolated adenovirus, virus-like particle, vector, composition, cell and in vitro method for the production of an adenovirus or adenovirus-like particle

机译:多核苷酸,分离的腺病毒,病毒样颗粒,载体,组成,细胞和体外制备腺病毒或腺病毒样颗粒的方法

摘要

the present invention relates to new strains of adenovirus with high immunogenicity and without pre-existing immunity in the human population in general. the lack of pre-existing immunity is due to new hypervariable regions in the hexon protein of the adenoviral capsid. the new adenovirus strains also have an improved reproductive capacity. the present invention provides nucleotide sequences and amino acid sequences of these new adenovirus strains, as well as recombinant viruses, virus-like particles (vlps) and vectors based on those strains. in addition, pharmaceutical compositions and medical uses are provided in therapy or prophylaxis of a disease and methods for producing an adenovirus or virus-like particles using the new sequences, recombinant viruses, virus-like particles and vectors.
机译:一般而言,本发明涉及具有高免疫原性并且在人群中没有预先存在的免疫力的新型腺病毒株。缺乏先前存在的免疫力是由于腺病毒衣壳六邻体蛋白中出现了新的高变区。新的腺病毒株也具有提高的繁殖能力。本发明提供了这些新的腺病毒株的核苷酸序列和氨基酸序列,以及基于这些株的重组病毒,病毒样颗粒(vlps)和载体。另外,提供了用于治疗或预防疾病的药物组合物和医学用途,以及使用新序列,重组病毒,病毒样颗粒和载体生产腺病毒或病毒样颗粒的方法。

著录项

  • 公开/公告号BR112020000145A2

    专利类型

  • 公开/公告日2020-07-14

    原文格式PDF

  • 申请/专利权人 NOUSCOM AG;

    申请/专利号BR20201100145

  • 申请日2018-07-05

  • 分类号C07K14/005;C12N7;C12N15/86;

  • 国家 BR

  • 入库时间 2022-08-21 11:18:18

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号